Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 141Active not recruiting 58Completed 34Not yet recruiting 26Terminated 12Enrolling by invitation 4Suspended 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Head & Neck 4Thoracic 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 33Breast Neoplasms 17Prostatic Neoplasms 15Colorectal Neoplasms 12Hematologic Neoplasms 7Lung Neoplasms 6Stomach Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Myasthenia Gravis 4Melanoma 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma 4Urinary Bladder Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Hematopoietic and Lymphatic System Neoplasm 3Hematologic Diseases 3Head and Neck Neoplasms 3Glioma 3Gastrointestinal Neoplasms 3Disease 3Colonic Neoplasms 3

Interventions

Tramadol 1Pregabalin 1Naproxen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Squamous Cell Carcinoma of Head and Neck × 90 days × Clear all
NCT07606638 2026-05-26

Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients

Mayo Hospital Lahore

Phase NA Enrolling by invitation
98 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT06885424 2026-05-20

DESCENT-1

A2 Biotherapeutics Inc.

Enrolling by invitation
400 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07550972 2026-04-24

Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.

Zhejiang Provincial People's Hospital

Phase 2 Enrolling by invitation
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07532928 2026-04-16

A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data

Nanfang Hospital, Southern Medical University

Enrolling by invitation
571 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡